141 related articles for article (PubMed ID: 8092994)
1. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.
Sahu A; Kozel TR; Pangburn MK
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):429-36. PubMed ID: 8092994
[TBL] [Abstract][Full Text] [Related]
2. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
[TBL] [Abstract][Full Text] [Related]
4. The structure of complement C3b provides insights into complement activation and regulation.
Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
[TBL] [Abstract][Full Text] [Related]
5. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3.
Sahu A; Pangburn MK
Biochem Pharmacol; 1996 Mar; 51(6):797-804. PubMed ID: 8602875
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine is a potential site for covalent attachment of activated complement component C3.
Sahu A; Pangburn MK
Mol Immunol; 1995 Jul; 32(10):711-6. PubMed ID: 7659097
[TBL] [Abstract][Full Text] [Related]
7. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
8. Binding reaction between the third human complement protein and small molecules.
Law SK; Minich TM; Levine RP
Biochemistry; 1981 Dec; 20(26):7457-63. PubMed ID: 7326238
[TBL] [Abstract][Full Text] [Related]
9. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
10. Structural insights on complement activation.
Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
[TBL] [Abstract][Full Text] [Related]
11. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
Grossman N; Joiner KA; Frank MM; Leive L
J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413
[TBL] [Abstract][Full Text] [Related]
12. The tick-over theory revisited: is C3 a contact-activated protein?
Nilsson B; Nilsson Ekdahl K
Immunobiology; 2012 Nov; 217(11):1106-10. PubMed ID: 22964236
[TBL] [Abstract][Full Text] [Related]
13. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
14. Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodies.
MacGill TC; MacGill RS; Kozel TR
Infect Immun; 2001 Feb; 69(2):1189-91. PubMed ID: 11160020
[TBL] [Abstract][Full Text] [Related]
15. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
16. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
[No Abstract] [Full Text] [Related]
17. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
19. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
McFadden DC; Fries BC; Wang F; Casadevall A
Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for sialic acid-mediated self-recognition by complement factor H.
Blaum BS; Hannan JP; Herbert AP; Kavanagh D; Uhrín D; Stehle T
Nat Chem Biol; 2015 Jan; 11(1):77-82. PubMed ID: 25402769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
